Vaccine Cover-Up Scandal: What FDA Knew

A Senate investigation now alleges Biden-era health officials saw COVID-19 vaccine safety red flags early—and stuck with a surveillance approach that could hide them.

Quick Take

Sen. Ron Johnson released a 39-page report tied to the Permanent Subcommittee on Investigations alleging FDA/HHS leaders ignored or concealed vaccine “safety signals” during the 2021 rollout.
The report centers on a technical issue called “masking,” where an older algorithm used for VAERS data mining could bury statistically significant warning patterns.
Documents cited in the report include briefings and internal emails, plus a large HHS document production that investigators say followed years of delays.
Supporters argue the findings justify criminal referrals; skeptics counter that VAERS limits and statistical uncertainty make sweeping injury estimates difficult to prove.

What Johnson’s report claims the FDA knew in early 2021

Sen. Ron Johnson (R-Wis.) says his new report traces warnings given to senior FDA leadership during the first months of the vaccine rollout. The timeline highlighted in the report says Dr. Anna Szarfman, described as a primary vaccine-safety data specialist, briefed CBER Director Peter Marks on March 1, 2021, that the agency’s existing approach could “mask” or hide safety signals in the data. Johnson argues the issue was not academic, but tied to real-world decision-making during mandates and licensure efforts.

The report further states that on March 27, 2021—26 days after the initial warning—FDA officials were shown results from a more advanced algorithm attributed to Oracle statistician Dr. William DuMouchel. Johnson’s summary says the newer method revealed 49 cases of “extreme masking” and roughly 20–25 statistically significant safety signals that had been obscured. The report also says Szarfman continued providing updated findings as vaccine policies expanded in 2021.

Why “masking” and VAERS methodology matter for accountability

VAERS, the Vaccine Adverse Event Reporting System, is a longstanding passive reporting database jointly operated by FDA and CDC. Passive systems can miss cases and can also include reports that are not proven to be caused by a product. Johnson’s report focuses on the narrower question of whether FDA leaders used a statistical approach they were warned could bury patterns worth investigating. If an agency knows its tools can hide signals, choosing not to upgrade becomes a governance issue, not a partisan talking point.

That technical dispute is also where the public debate gets messy. Johnson allies point to underreporting estimates and argue the true scale of harm could be much larger than what appears in VAERS. Skeptics respond that extrapolating from VAERS capture rates requires heavy assumptions and still does not establish causation. The available research here supports both realities: VAERS has limitations, and masking is a known phenomenon in pharmacovigilance. The report’s central test will be documentation showing what leaders knew, when they knew it, and what they decided.

Document fights with HHS and the “deep state” trust gap

Johnson’s team says the report is backed by a major document production—about 115,000 pages—from HHS, following what investigators describe as years of delay and incomplete responses to oversight requests. The report points to internal emails that it interprets as a preference for off-email discussions, which the investigators frame as a transparency problem. For Americans already convinced bureaucracies protect themselves first, that pattern reinforces a familiar fear: systems meant to serve citizens can be turned inward to shield reputations and careers.

Political and policy stakes under a GOP-led Washington in 2026

With President Trump in a second term and Republicans controlling Congress, Johnson’s report lands in a Washington environment more willing to litigate the pandemic era and less willing to defer to public-health authorities. Johnson has raised the prospect of criminal accountability, while the report’s defenders argue that mandates and messaging in 2021 increased the duty to surface safety uncertainties quickly. At the same time, the research provided here shows no documented FDA or HHS response included in the record, limiting what can be concluded beyond the report’s allegations.

COVID COVER-UP: SENATOR REVEALS WHAT WAS KNOWN UNDER BIDEN@SenRonJohnson releases a groundbreaking report alleging Biden health officials ignored serious COVID19 vaccine safety signals. "Adverse events are rare and mild…we have debunked that…this is a BLOCKBUSTER report."… pic.twitter.com/ibBBU4IdNB

— Real America's Voice (RAV) (@RealAmVoice) May 9, 2026

For everyday Americans—conservative, liberal, and exhausted—this story is less about reliving COVID arguments and more about whether federal agencies can be trusted in the next emergency. If oversight finds that warnings were sidelined and tools were kept in place despite known blind spots, Congress will face pressure to harden transparency rules, modernize safety surveillance, and reduce incentives for institutional self-protection. If key claims prove overstated, the country still inherits the same core problem: eroded trust in government competence and candor.